GlassScriptPhysician profile
Leonardo Cortez
NPI 1497845937
$3,606.46
in general payments reported to CMS, 2019-2025
21 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $604 · 2020: $781 · 2021: $640 · 2022: $518 · 2023: $373 · 2024: $457 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,063.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,109.46 | 2019-2025 | Evenity, Prolia, Otezla |
| Glaxosmithkline, LLC. | $490.07 | 2020-2025 | Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $449.38 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $348.38 | 2019-2024 | Breztri, Airsupra |
| Lilly USA, LLC | $200.80 | 2020-2025 | Mounjaro, Zepbound, Trulicity |
| Novo Nordisk INC | $184.22 | 2020-2024 | Rybelsus, Ozempic |
| Janssen Pharmaceuticals, INC | $151.86 | 2020-2024 | Xarelto |
| Kowa Pharmaceuticals America, INC. | $123.81 | 2019-2022 | |
| Pfizer INC. | $121.51 | 2020-2024 | |
| Merck Sharp & Dohme LLC | $57.59 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $53.98 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $51.19 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $50.25 | 2022-2023 | Eliquis |
| Eisai INC. | $49.63 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.65 | 2019-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $29.27 | 2021 | |
| Myriad Genetic Laboratories, INC. | $25.67 | 2021 | |
| Avanir Pharmaceuticals, INC. | $25.45 | 2021 | |
| Esperion Therapeutics, INC. | $15.38 | 2025 | Nexletol |
| Radius Health, INC. | $14.88 | 2019 | |
| Horizon Therapeutics Plc | $14.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonardo Cortez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.